News from immunovia ab A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Sep 23, 2020, 10:46 ET Summary from The Extraordinary General Meeting of Immunovia

Extraordinary General Meeting of Immunovia AB (publ), Corp. Reg. No. 556730-4299 was held at The Spark in Medicon Village, Scheeletorget 1, Lund,...


Sep 02, 2020, 02:48 ET Immunovia Announces Management Team Changes

Immunovia AB (publ) ("Immunovia") a near-commercial stage diagnostics company developing ground-breaking antibody-based multiplex microarray...


Aug 31, 2020, 02:45 ET Notice of Extraordinary General Meeting in Immunovia AB

The Board of Directors of Immunovia AB (publ), corporate identity number 556730-4299, hereby convenes an Extraordinary General Meeting on Wednesday,...


Aug 28, 2020, 03:16 ET Registration Details for Immunovia's Second Webinar in the Series on IMMray™ PanCan-d: Commercial Test Model Study & Update on Launch Activities

Immunovia AB (publ) ("Immunovia"), today announced that the company will be hosting the second webinar in the series on Immunovia's IMMray™ PanCan-d. ...


Aug 26, 2020, 02:45 ET Immunovia Announces CEO Transition: Appoints Patrik Dahlen as New CEO

Immunovia AB (publ) ("Immunovia"), today announced that the Board of Directors has appointed Patrik Dahlen as new CEO starting November 1, 2020....


Aug 20, 2020, 10:33 ET Immunovia Reports Second Quarter Interim Report January - June 2020

Immunovia has today published second quarter interim report for January - June 2020. It is available on Immunovia's website. "During Q2, we...


Aug 18, 2020, 03:13 ET Immunovia to Host a Second Webinar in the Series on IMMray™ PanCan-d: Commercial Test Model Study & Update on Launch Activities

Immunovia AB (publ) ("Immunovia"), today announced that the company will be hosting the second webinar in the series on Immunovia's IMMray™ PanCan-d. ...


Aug 13, 2020, 02:16 ET Invitation to presentation of Immunovia's interim report January - June 2020 on August 20, 2020

Immunovia invites to a teleconference (in English) for investors, analysts and media on Thursday, August 20th, 2020 at 16:30 CET. Immunovia will...


Jun 30, 2020, 03:16 ET Change in the Number of Shares and Votes in Immunovia AB (publ)

Immunovia AB (publ) ("Immunovia") today announced that the number of shares and votes in Immunovia has changed due to the fact that shares have been...


Jun 30, 2020, 03:07 ET Immunovia Targeting Long-Term Market Penetration of 30% for IMMray™ PanCan-d

Immunovia AB (publ) ("Immunovia") today announced the company's long-term market penetration target of 30% for IMMray™ PanCan-d, after reimbursement...


Jun 29, 2020, 11:10 ET Immunovia to Present a Satellite Symposium at the European Pancreatic Club (EPC) - International Association of Pancreatology's (IAP) Annual Meeting July 2, 2020

Immunovia AB (publ) ("Immunovia") today announced the company will be presenting at the 52nd EPC-IAP annual meeting on July 2, 2020. This year's...


Jun 26, 2020, 09:20 ET Registration Details for Immunovia's Virtual Investor Day on Tuesday, June 30, 2020

Immunovia AB (publ) ("Immunovia") today announced the registration details for the company's Virtual Investor Day on Tuesday, June 30, 2020, from...


Jun 26, 2020, 03:29 ET Immunovia Expands its Lung Cancer Program Based on Encouraging Results From the Current Discovery Study

Immunovia AB (publ) ("Immunovia") today announced that the results of the current study in lung cancer strongly supports an expansion into the next...


Jun 15, 2020, 11:40 ET Immunovia to Host Virtual Investor Day on Tuesday, June 30, 2020

Immunovia AB (publ) ("Immunovia") today announced the company will host a Virtual Investor Day on Tuesday, June 30, 2020, from 2:00 to 4:00 pm CET....


Jun 09, 2020, 12:21 ET Immunovia Raised ~ 400m SEK to Further Accelerate the Market Introduction of the First Test for Early Detection of Pancreatic Cancer, the IMMray™ PanCan-d

On June 4th, Immunovia announced a Directed Share Issue raising ~400 MSEK in capital, resulting in one of the largest fundraising for a non-US based...


Jun 04, 2020, 03:24 ET Immunovia has Completed a Directed Share Issue and Thereby Raises Approximately MSEK 400

INSIDE INFORMATION: The Board of Directors of Immunovia AB (publ) ("Immunovia" or the "Company") has, in accordance with the announcement made in a...


May 27, 2020, 10:31 ET Immunovia Provides Forth Update During COVID-19 Pandemic

Immunovia AB (publ) ("Immunovia") today provides an update on the actions that the company is taking in response to the coronavirus (COVID-19)...


May 25, 2020, 22:57 ET Invitation to Immunovia's Update #4 on COVID-19 Company Response

Immunovia invites you to a teleconference (in English) for all stakeholders and media on Wednesday, May 27, 2020 at 16:30 CET. Mats Grahn, CEO will...


May 13, 2020, 10:17 ET Immunovia Provides Third Update During COVID-19 Pandemic

Immunovia AB (publ) ("Immunovia") today provides an update on the actions that the company is taking in response to the coronavirus (COVID-19)...


May 12, 2020, 12:25 ET Invitation to Immunovia's Update #3 on COVID-19 Company Response

Immunovia invites you to a teleconference (in English) for all stakeholders and media on Wednesday, May 13, 2020 at 16:30 CET. Mats Grahn, CEO will...


May 08, 2020, 07:24 ET Immunovia - Report From AGM

The Annual General Meeting (AGM) of Immunovia AB (publ), corporate identity number 556730-4299 was held in The Spark at Medicon Village,...


Apr 28, 2020, 10:26 ET Immunovia Reports First Quarter Interim Report January - March 2020

Immunovia has today published first quarter interim report for January - March 2020. It is available on Immunovia's website. "During Q1 2020,...


Apr 22, 2020, 11:48 ET Invitation to Presentation of Immunovia's Interim Report January - March 2020 on April 28, 2020

Immunovia invites to a teleconference (in English) for investors, analysts and media on Tuesday, April 28th, 2020 at 16:30 CET. Immunovia will...


Apr 08, 2020, 03:08 ET Immunovia and Global Pharmaceutical Company Agree on Early Termination of Lung Cancer Collaboration

Immunovia AB (publ) ("Immunovia") today announced that the company's Lung Cancer collaboration with a global pharmaceutical company has been...


Apr 01, 2020, 10:12 ET Immunovia Takes Action During COVID-19 Pandemic and Remains Focused on Launch of IMMray™ PanCan-d

Immunovia AB (publ) ("Immunovia") today provides an update on the actions that the company is taking to support patients, employees, and public...